We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+11.96%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$10.1B
AUM Growth
+$1.16B
Cap. Flow
-$151M
Cap. Flow %
-1.49%
Top 10 Hldgs %
46.75%
Holding
616
New
9
Increased
46
Reduced
197
Closed
62

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$14.4M
2
PAYC icon
Paycom
PAYC
+$10.8M
3
VEEV icon
Veeva Systems
VEEV
+$9.74M
4
PH icon
Parker-Hannifin
PH
+$4.8M
5
WEX icon
WEX
WEX
+$4.15M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$50.9M
2
MA icon
Mastercard
MA
+$21.1M
3
EW icon
Edwards Lifesciences
EW
+$19.4M
4
MSFT icon
Microsoft
MSFT
+$12.3M
5
AAPL icon
Apple
AAPL
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 39.56%
2 Healthcare 17.19%
3 Financials 10.67%
4 Consumer Discretionary 10.19%
5 Communication Services 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIG icon
101
Vanguard Dividend Appreciation ETF
VIG
$115B
$2.63M 0.03%
15,260
BDX icon
102
Becton Dickinson
BDX
$50B
$2.62M 0.03%
10,983
-576
-5% -$142K
AVGO icon
103
Broadcom
AVGO
$1.98T
$2.58M 0.03%
21,830
+320
+1% +$30.3K
SEM
104
DELISTED
Select Medical
SEM
$2.56M 0.03%
182,558
SYY icon
105
Sysco
SYY
$40.5B
$2.46M 0.02%
30,360
+149
+0.5% +$10.3K
DFS
106
DELISTED
Discover Financial Services
DFS
$2.37M 0.02%
22,481
NVO
107
Novo Nordisk
NVO
$203B
$2.34M 0.02%
20,436
HSY icon
108
Hershey
HSY
$37B
$2.3M 0.02%
11,900
+1,211
+11% +$229K
CMI icon
109
Cummins
CMI
$87.8B
$2.28M 0.02%
9,525
+75
+0.8% +$17.1K
QQQ icon
110
Invesco QQQ Trust
QQQ
$481B
$2.26M 0.02%
5,425
-25
-0.5% -$9.49K
IBM icon
111
IBM
IBM
$222B
$2.22M 0.02%
12,083
-93
-0.8% -$14.1K
GNRC icon
112
Generac Holdings
GNRC
$13.1B
$2.18M 0.02%
19,142
-10,469
-35% -$1.15M
GLD icon
113
SPDR Gold Trust
GLD
$144B
$2.17M 0.02%
11,527
UNH icon
114
UnitedHealth
UNH
$364B
$2.14M 0.02%
4,190
-115
-3% -$61.3K
MS icon
115
Morgan Stanley
MS
$342B
$2.09M 0.02%
23,997
DD icon
116
DuPont de Nemours
DD
$19.5B
$2.06M 0.02%
26,500
-271
-1% -$24.6K
PFE icon
117
Pfizer
PFE
$150B
$2.01M 0.02%
74,352
-1,500
-2% -$45.3K
MKC icon
118
McCormick & Company Non-Voting
MKC
$14.2B
$1.93M 0.02%
28,378
-1,789
-6% -$117K
IQV icon
119
IQVIA
IQV
$39.8B
$1.91M 0.02%
9,184
-7,475
-45% -$1.53M
VOO icon
120
Vanguard S&P 500 ETF
VOO
$1.03T
$1.84M 0.02%
4,141
+3,376
+441% +$1.38M
GE icon
121
GE Aerospace
GE
$379B
$1.81M 0.02%
17,118
-63
-0.4% -$5.84K
CB icon
122
Chubb
CB
$132B
$1.78M 0.02%
7,270
DOW icon
123
Dow Inc
DOW
$22.1B
$1.73M 0.02%
32,300
IVV icon
124
iShares Core S&P 500 ETF
IVV
$904B
$1.71M 0.02%
3,525
-30
-0.8% -$13.4K
BMY icon
125
Bristol-Myers Squibb
BMY
$130B
$1.61M 0.02%
32,961
-13,855
-30% -$727K

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Loring Wolcott & Coolidge Fiduciary Advisors held 616 positions worth $10.1B, up 13% from $8.93B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2023 filing shows 9 new, 46 increased, 197 reduced and 62 closed positions. Its largest new stake was Keurig Dr Pepper: 6,000 shares worth $189K. The largest sale was Danaher, an estimated $50.9M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2023 buy was Keurig Dr Pepper: 6,000 shares worth $189K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Regeneron Pharmaceuticals in Q4 2023, an estimated $14.4M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2023 reduction was Danaher, cutting an estimated $50.9M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Amcor in Q4 2023, selling an estimated $1.02M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 47% of its $10.1B portfolio in Q4 2023.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 9 new positions and closed 62 in Q4 2023.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 13% quarter-over-quarter to $10.1B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.